NCT05489601 is a clinical trial of Oxycodone in Neurologic Impairment by Opioids, sponsored by Zxerex Corporation.

Who is sponsoring NCT05489601?

NCT05489601 is sponsored by Zxerex Corporation.

What drugs are being tested in NCT05489601?

Interventions in NCT05489601: Oxycodone.

What condition does NCT05489601 study?

NCT05489601 studies Neurologic Impairment by Opioids.

Is NCT05489601 still recruiting?

NCT05489601 is currently completed. Last updated 5 August 2022.

Last reviewed 2022-08-05 · How we verify

NCT05489601

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Non-intrusive Detection of Temporary Neurologic Impairment by Opioids

Completed Last updated 5 August 2022

What this trial tests

trial testing Oxycodone in Neurologic Impairment by Opioids in 17 participants. Completed in 29 March 2022.

Timeline

28 February 2020

Primary endpoint
29 March 2022

29 March 2022

Quick facts

Lead sponsor	Zxerex Corporation
Status	Completed
Study type	OBSERVATIONAL
Enrollment	17
Start date	28 February 2020
Primary completion	29 March 2022
Estimated completion	29 March 2022
Sites	1 location across United States

Drugs / interventions tested

Oxycodone (oxycodone) — full drug profile →

Conditions studied

Neurologic Impairment by Opioids — all drugs for Neurologic Impairment by Opioids →

Sponsor

Zxerex Corporation

Who can join

Adults 21 to 59, any sex, with Neurologic Impairment by Opioids. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to prove the feasibility of a non-invasive means to identify temporary neurological impairment resulting from the use of a commonly prescribed opioid by identifying an oculomotor biosignature associated with temporary neurologic impairment in pain-free opioid-naïve subjects, and to initiate the development of such a signature. The investigators also sought to establish the presence of a dose-dependent biosignature for opioid impairment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Oxycodone

Trials testing the same drug.

NCT07153003 — Efficacy And Safety Of Tramadol And Oxycodone Versus Oxycodone Monotherapy For Pain Control After Primary Total Knee And · Phase 4 · enrolling by invitation
NCT06757140 — Opioid Drug Interaction Study · Phase 1, PHASE2 · recruiting
NCT05965492 — Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery · Phase 3 · withdrawn
NCT06517069 — Effect of TEAS Combined With Oxycodone on Postoperative Visceral Pain in Gynecologic Laparoscopic Patients · NA · recruiting
NCT06340932 — Impact of Opioid Avoidance Protocol for ACL Reconstruction · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05489601 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zxerex Corporation
Last refreshed: 5 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05489601.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing